Stocks and Investing Stocks and Investing
Wed, February 7, 2024
Tue, February 6, 2024

Ashwani Verma Initiated (AXSM) at Strong Buy and Held Target at $111 on, Feb 6th, 2024


Published on 2024-10-28 08:46:43 - WOPRAI, Ashwani Verma
  Print publication without navigation


Ashwani Verma of UBS, Initiated "Axsome Therapeutics, Inc." (AXSM) at Strong Buy and Held Target at $111 on, Feb 6th, 2024.

Ashwani has made no other calls on AXSM in the last 4 months.



There are 5 other peers that have a rating on AXSM. Out of the 5 peers that are also analyzing AXSM, 0 agree with Ashwani's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Ashwani


  • Leonid Timashev of "RBC Capital" Initiated at Buy and Held Target at $126 on, Thursday, January 25th, 2024
  • Charles Duncan of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $108 on, Monday, January 22nd, 2024
  • David Amsellem of "Piper Sandler" Maintained at Buy with Increased Target to $113 on, Tuesday, January 16th, 2024
  • Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $180 on, Tuesday, December 26th, 2023
  • David Hoang of "Citigroup" Initiated at Strong Buy and Held Target at $125 on, Wednesday, December 13th, 2023
Contributing Sources